The largest database of trusted experimental protocols

LC Laboratories

281 cited products 3 398 protocol citations
LC Laboratories is a leading supplier of high-quality products for scientific research and development.
The company offers a diverse range of equipment, consumables, reagents, and chemicals tailored to support a wide variety of research applications.
Researchers can explore detailed citation data, find product usage in publications, preprints, and patents on the PubCompare.ai platform to support their scientific endeavors.
LC Laboratories' products are extensively utilized in research protocols, providing comprehensive insights to help researchers leverage the latest supplier offerings and advance their scientific discoveries.

281 products from LC Laboratories

Cited in 609 protocols
Sourced in United States, Germany, United Kingdom, Canada, Morocco, Macao
Rapamycin is a macrolide compound produced by the bacterium Streptomyces hygroscopicus. It functions as an immunosuppressant and has been used in research applications.
Cited in 131 protocols
Sourced in United States
Bortezomib is a chemical compound produced by LC Laboratories. It is a proteasome inhibitor that is used in research applications.
Cited in 115 protocols
Sourced in United States, Macao, United Kingdom
Dasatinib is a tyrosine kinase inhibitor. It is a small-molecule drug designed to inhibit the activity of several protein kinases, including BCR-ABL, SRC family kinases, c-KIT, PDGFR, and EPHA2.
Cited in 93 protocols
Sourced in United States, United Kingdom, Germany
Erlotinib is a laboratory product available from LC Laboratories. It is a small-molecule tyrosine kinase inhibitor.
Cited in 90 protocols
Sourced in United States, Germany
Sorafenib is a small-molecule tyrosine kinase inhibitor. It is a white to slightly yellow solid.
Cited in 85 protocols
Sourced in United States
Lapatinib is a small-molecule tyrosine kinase inhibitor. It functions by selectively inhibiting the intracellular tyrosine kinase domains of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2).
Cited in 75 protocols
Sourced in United States, China
Imatinib is a small molecule inhibitor. It is used as a laboratory reagent for research purposes.
Cited in 62 protocols
Sourced in United States
Gefitinib is a small-molecule tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR). It is commonly used in laboratory research and development.
Cited in 57 protocols
Sourced in United States, Canada
Paclitaxel is a chemically synthesized compound used for research and development purposes. It is a microtubule-stabilizing agent commonly employed in the study of cell biology and cancer research.
Cited in 50 protocols
Sourced in United States
Trametinib is a small molecule inhibitor that targets the mitogen-activated protein kinase (MAPK) signaling pathway. It inhibits the activity of the enzymes MEK1 and MEK2, which are part of the MAPK/ERK signaling cascade.

Company FAQ

Is this your company ?

Claim your company profile and access business tools

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!